Market closed

Neumora Therapeutics/$NMRA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Neumora Therapeutics

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Ticker

$NMRA
Trading on

Industry

Pharmaceuticals

Employees

110

NMRA Metrics

BasicAdvanced
$138M
-
-$1.53
-
-
$138M
$11.57
$0.84
1.3M
10.508
10.292
0.646
-40.50%
-64.48%
0.48
0.48
-0.737
-57.84%
-47.93%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NMRA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Neumora Therapeutics stock?

Neumora Therapeutics (NMRA) has a market cap of $138M as of April 05, 2025.

What is the P/E ratio for Neumora Therapeutics stock?

The price to earnings (P/E) ratio for Neumora Therapeutics (NMRA) stock is 0 as of April 05, 2025.

Does Neumora Therapeutics stock pay dividends?

No, Neumora Therapeutics (NMRA) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Neumora Therapeutics dividend payment date?

Neumora Therapeutics (NMRA) stock does not pay dividends to its shareholders.

What is the beta indicator for Neumora Therapeutics?

Neumora Therapeutics (NMRA) does not currently have a Beta indicator.